UnitedHealth's HouseCalls: Clinical Care or Revenue Optimization?

  unitedhealth-s-housecalls-clinical-care-or-revenue-optimization.html
  Health and Fitness on Tue, Jul 07th, 2026 by Seeking Alpha
      Locale: UNITED STATES

The Mechanics of the HouseCalls Program

At its core, the HouseCalls initiative is designed as a preventative health measure. By conducting in-home assessments, UnitedHealth aims to identify health risks, manage chronic conditions, and address social determinants of health that may not be apparent during a standard clinic visit. The theoretical objective is to create a comprehensive health profile for the patient, allowing for more personalized care coordination and a reduction in avoidable emergency room visits and hospitalizations.

From a clinical perspective, the company defends these visits as a critical tool for patient equity. Home visits allow providers to see the actual living conditions of the patient—such as medication storage, mobility hazards, and nutritional access—which provides a holistic view of the patient's health status that is unattainable in a traditional office setting.

The Audit Conflict: Clinical Value vs. Revenue Optimization

The current friction arises from an external audit focusing on the necessity and intent of these home visits. The central tension lies in the relationship between these assessments and the Medicare Advantage risk-adjustment model.

Under the Medicare Advantage system, the federal government pays insurance providers based on the "risk score" of their members. Patients with more severe or numerous chronic conditions carry higher risk scores, which in turn trigger higher monthly payments from the Centers for Medicare & Medicaid Services (CMS) to the insurer.

Regulators and auditors are investigating whether the HouseCalls program is utilized primarily to improve patient health, or if it serves as a mechanism for "upcoding." Upcoding occurs when a provider identifies and documents additional diagnoses—some of which may be minor or historically stable—specifically to increase the patient's risk score and, consequently, the reimbursement payment from the government. The concern is that the in-home nature of these visits provides an opportunistic environment to find "forgotten" diagnoses that do not necessarily require active treatment but do increase the insurer's revenue.

UnitedHealth's Defense

UnitedHealth has vigorously defended the program, asserting that the external audit overlooks the tangible clinical benefits provided to members. The company maintains that the HouseCalls program is a cornerstone of its value-based care strategy. By proactively managing health in the home, UnitedHealth argues that it prevents the escalation of illnesses, thereby lowering the overall cost of care in the long run and improving the quality of life for seniors.

The company posits that the documentation resulting from these visits is an accurate reflection of the patient's health status, not an attempt to inflate billing. They argue that identifying a condition in the home is a legitimate clinical discovery that allows for better care management, regardless of the subsequent impact on risk scores.

Broader Industry Implications

This dispute is not an isolated incident but rather a symptom of a broader systemic scrutiny of the Medicare Advantage industry. The U.S. government has increased its focus on how insurers manage risk adjustment, fearing that the system is being gamed to divert billions of taxpayer dollars into corporate profits.

If the audit concludes that the HouseCalls model was used inappropriately to drive revenue, it could lead to significant financial clawbacks and a mandatory restructuring of how home assessments are conducted and documented. Furthermore, it may set a precedent for how other insurers utilize similar home-visit programs, potentially shifting the industry away from aggressive documentation and toward a more conservative, treatment-focused approach.

As the audit continues, the outcome will likely determine the balance between the ability of insurers to conduct proactive outreach and the government's requirement to ensure that payments are based on actual medical necessity rather than administrative optimization.